Skip to content

Clinical trials

Lymphoma, B-Cell trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: Austria Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20161
20193
20203
20214
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting5
Recruiting3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Novartis Pharmaceuticals3
Celgene2
Hoffmann-La Roche2
Regeneron Pharmaceuticals2
Acerta Pharma BV1
BeOne Medicines1
Curon Biopharmaceutical (Australia) Co Pty Ltd1
Sandoz1
University of Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell18
Lymphoma, Non-Hodgkin8
Lymphoma, Large B-Cell, Diffuse5
Hematologic Diseases4
Lymphoma4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Follicular3
Lymphoma, Mantle-Cell2
Neoplasms2
Recurrence2

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.